Comparing limited and intense follow-up care for patients with stage II-III soft tissue sarcoma
Official title: Evaluating the Impact of Limited vs. Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Soft Tissue Sarcoma
Run by M.D. Anderson Cancer Center · NCT04751409 · Data updated 2026-11-12
This study is testing whether more frequent follow-up visits or fewer visits after surgery can help reduce anxiety and improve outcomes for patients with stage II-III soft tissue sarcoma.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 227 (estimated) |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | December 28, 2020 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | September 14, 2026 |
| Trial ID | NCT04751409 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who have completed sarcoma therapy within 8-14 weeks and are willing to participate in surveys for two years.
✕Probably not a fit
Patients with documented metastatic disease at enrollment or those who are non-English-speaking may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This phase II trial investigates the effects of two different follow-up approaches on anxiety levels in patients who have undergone surgery for stage II-III soft tissue sarcoma. Participants are divided into low-risk and high-risk groups, with low-risk patients receiving either intense follow-up every three months or limited follow-up every six months. The study aims to assess how these follow-up strategies impact patient anxiety, overall survival, and other cancer-related outcomes over a two-year period. By evaluating the psychological and logistical implications of surveillance frequency, the trial seeks to optimize post-operative care for sarcoma patients.
Why it matters
Potential benefit: If successful, this study could lead to improved mental health outcomes for patients by reducing anxiety associated with post-operative surveillance.
How similar studies have gone: Other studies have explored follow-up strategies in cancer care, but this specific comparison of surveillance intensity in soft tissue sarcoma is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
IInclusion Criteria: * ≥18 years old * Completion of sarcoma therapy (chemotherapy, radiation therapy and/or surgery) within 8-14 weeks of study enrollment * Willingness to complete surveys x 2 years Exclusion Criteria: * Documented metastatic disease at the time of enrollment * Non-English-speaking patients Pregnant women will be included in this clinical trial.
Where it's running
-
M D Anderson Cancer Center
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Christina L Roland, MD — M.D. Anderson Cancer Center
- Study coordinator: Christina L Roland, MD
- Email: clroland@mdanderson.org
- Phone: 713-792-6940
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Shorter radiation course vs standard course for soft tissue sarcoma of the limb/trunk
This trial tests whether a 5-day, ultrahypofractionated radiation therapy approach works as well as the standard 25-day course for soft tissue sarcoma that can be surgically removed.
-
Adding abemaciclib to gemcitabine chemotherapy for advanced soft tissue sarcoma
This phase 1/2 trial tests whether adding the targeted drug abemaciclib to gemcitabine is safe and works better than gemcitabine plus docetaxel for adults with advanced or metastatic leiomyosarcoma or dedifferentiated liposarcoma whose tumors are Rb-positive.
-
Combining immunotherapy with chemotherapy for aggressive sarcomas
This study is testing if combining immunotherapy with chemotherapy can help people with aggressive sarcomas live longer and feel better compared to just using chemotherapy alone.
-
Personalized exercise program to improve recovery for soft tissue sarcoma patients
This study is testing whether a personalized exercise program can help patients with soft tissue sarcoma recover better during their treatment compared to those who only receive educational materials.
-
Moderately Hypofractionated Neoadjuvant Radiotherapy for Soft Tissue Sarcoma of the Limbs or Trunk Wall
This trial tests whether giving a shorter course of radiotherapy before surgery helps control soft tissue sarcoma in the limbs or trunk without waiting longer.
-
Personalised neoadjuvant therapy planning for adults with high‑risk soft tissue sarcoma
This project tests whether analyzing tumor tissue and clinical data can help guide neoadjuvant chemotherapy decisions for adults with high‑risk soft tissue sarcomas.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.